Plain-English translation of NCT05570110 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing whether a medication called might help people with depression, especially those whose symptoms haven't improved adequately with current antidepressants. Researchers believe this medication may work by affecting how your body regulates stress hormones and blood pressure, both of which are connected to mood. Half of participants will receive the medication and half will receive a placebo (an inactive pill that looks identical).
About one-third of people with depression don't respond well enough to standard antidepressant medications. Researchers have discovered that certain patterns in stress hormone levels and heart rate control may explain why some people struggle to get better, and this medication might help reverse those patterns.
You likely qualify if…
You likely don't qualify if…
You will take a capsule daily—either the study medication or placebo—while researchers monitor your depression symptoms, blood pressure, heart rate, and stress hormone levels through regular blood tests and overnight urine collections. The study will track whether certain health markers predict how well the treatment works for you, comparing those with different baseline blood pressure levels and hormone patterns. Your participation helps researchers understand whether this medication could one day help people with hard-to-treat depression.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Germany